“Herd Immunity” is Not an Answer to a Pandemic – Infectious Diseases Society of America Commentary on Twitter https://t.co/k15V8bMjiK via @IDSAInfo Excellent statement from @IDSAInfo & @HIVMA Presidents of why "herd immunity" is not an answer to a pandemic. These is the professional association representing > 12K specialists in infectious diseases so these are […]
The post IDSA Position Statement: “Herd immunity” is not an answer to a pandemic appeared first on Links Medicus.
Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant – STAT News Release: Johnson & Johnson Temporarily Pauses All Dosing in Our Janssen COVID-19 Vaccine Candidate Clinical Trials Commentaries: Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment – […]
The post Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant appeared first on Links Medicus.
Monoclonal Antibody Trial Halted for Safety Concern – Brief19 Related: Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 ‘cure’ over safety concern – Reuters
The post Monoclonal antibody trial halted for safety concern appeared first on Links Medicus.
Genomic evidence for reinfection with SARS-CoV-2: a case study – The Lancet Infectious Diseases Commentaries: First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study – Health Policy Watch AND What reinfections mean for COVID-19 – The Lancet Infectious Diseases AND You can get […]
The post Genomic evidence for reinfection with SARS-CoV-2: A case study appeared first on Links Medicus.
Non-respiratory presentations of COVID-19, a clinical review – The American Journal of Emergency Medicine
The post Non-respiratory presentations of COVID-19, a clinical review appeared first on Links Medicus.
Coronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health See also: What’s New in the Guidelines
The post Updated NIH COVID-19 Treatment Guidelines appeared first on Links Medicus.
ECMO for severe ARDS: systematic review and individual patient data meta-analysis – Intensive Care Medicine Commentary on Twitter #ECMO vs conventional strategies in severe #ARDS, meta-analysis of individual patient data:#ECMO-group pts spent more days alive out of the #ICU & without respiratory, cardiovascular, renal, neurological failure. Open access @yourICM #FOAMcc #FOAMecmo https://t.co/3PV2gAHA3G https://t.co/k6MQYUjKgu — […]
The post Meta-analysis: ECMO for severe ARDS appeared first on Links Medicus.
Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics – medRxiv Commentary on Twitter Anyone think we prescribe too many #antibiotics in #COVID19? Looking for ways to prescribe less? Well, our latest *PREPRINT* (not peer reviewed!) may be of interest. #antibioticstewardship https://t.co/qUimnZhwg7 Thread (1/7) pic.twitter.com/Z6gaGMgduv — Gabriele Pollara […]
The post [Preprint] Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics appeared first on Links Medicus.
‘Long Covid’: Why are some people not recovering? – BBC
The post ‘Long Covid’: Why are some people not recovering? appeared first on Links Medicus.
Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID‐19 – Pharmacotherapy
The post Review: Coagulopathy, venous thromboembolism, and anticoagulation in patients with COVID‐19 appeared first on Links Medicus.